Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
**Background:** Atrial fibrillation (AF) is a chronic sustained heart rhythm disorder associated with an increased risk of stroke. Apixaban, a new oral anticoagulant, was approved by the European Medicines Agency for prevention of stroke in patients with AF. The efficacy of apixaban has been investi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | http://jheor.scholasticahq.com/article/9797-cost-effectiveness-of-apixaban-for-stroke-prevention-in-patients-with-atrial-fibrillation-in-algeria.pdf |